Protillion Biosciences, Inc., a leader in lab-in-the-loop AI drug design, today announced the signing of a multi-target ...

Gilead’s lenacapavir has been on the market since 2022, when it was approved in the U.S. as Sunlenca for twice-yearly ...

Merck KGaA leverages integrated global manufacturing, diversified segments, and innovation to maintain resilience and strategic momentum across pharma, life science, and electronics. MKKGY’s Q4 ...

For PhD student Anastasia Georgiou, it started with a click of a mouse and ended in the woods of Germany, at the home of Merck KGaA, one of the world's largest pharmaceutical corporations. In between, ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...

Alaska is a vast state with extremes in weather and terrain. For people living in its 240 remote villages and communities, obtaining lifesaving medicines can be a challenge. And extreme challenges ...

"It's not just an innovation center, it's also a collaboration center that will bring different forces together," said Rogier ...

One of Germany’s largest drugmakers is launching a seed fund to promote startups in China. In addition to creating the seed fund, Merck KGaA also opened an innovation hub in Shanghai and is planning ...

PathAI, a developer of artificial intelligence technology for use in pathology research, closed its Series B investment round Nov. 4, including participation from the Merck Global Health Innovation ...

Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up Editor’s note: This article is produced in ...

A diverse and inclusive workforce inspires innovation and is fundamental to our company’s success. Having an environment composed of people from different dimensions of diversity also helps us better ...

Merck, as a leading science and technology company, operates across healthcare, life sciences and performance materials. From advancing gene editing technologies and discovering unique ways to treat ...